Cameron Health Inc., a San Clemente medical device maker, has raised $14.1 million of a planned $50 million fifth round of funding, according to venture capital sources.
Versant Ventures, a venture capital firm with an office in Newport Beach, Sorrento Ventures, Delphi Ventures and Three Arch Capital are among the investors.
Cameron is developing an implantable defibrillator that administers shocks to the hearts of people who are at risk of a heart attack.
Cameron says its defibrillator is easier to use than existing models because it doesn’t require lead wires to be guided through the veins.
Such leads are both challenging to insert and can break in rare cases; broken leads have led to fatal shocks to the heart.
Cameron has attracted some heavy device hitters, in addition to its venture backing.
In 2004, Boston Scientific Corp. of Natick, Mass. bought part of the company for an undisclosed price.
